| Line item | 2025-11-02 FY | 2024-10-27 FY | 2023-10-29 FY | 2022-10-30 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $45.68B | $51.72B | $61.25B | $52.58B | $44.02B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $2.31B | $2.29B | $2.18B | $1.91B | $1.59B |
| SG&A | $4.66B | $4.84B | $4.59B | $3.86B | $3.38B |
| Operating Income | – | $9.04B | $12.96B | $9.51B | $8.01B |
| Interest Expense | $3.17B | $3.35B | $2.45B | $1.06B | $993.00M |
| Tax Expense | $1.26B | $2.09B | $2.87B | $2.01B | $1.66B |
| Net Income | $5.03B | $7.10B | $10.17B | $7.13B | $5.96B |
| EPS (basic) | 18.5500 | 25.7300 | 34.8000 | 23.4200 | 19.1400 |
| EPS (diluted) | 18.5000 | 25.6200 | 34.6300 | 23.2800 | 18.9900 |
| Shares (diluted) | $271.70M | $277.10M | $293.60M | $306.30M | $314.00M |